Back to search
FDAFDA · Food and drugs·Recall number D-0473-2024

Cloderm (clocortolone pivalate) Cream, 0.1%, Rx Only, For Topical Use Only, Net Wt 45g, Manufactured for: EPI Health, LLC, Charleston, SC 29403, NDC 71403-804-90

Published May 1, 2024 · Recall initiated: April 23, 2024

Summary

FDA records drug Class II recall D-0473-2024, published May 1, 2024 and initiated April 23, 2024. Recalling firm: EPI Health, LLC; Status: Terminated; Reported quantity: 18645 tubes; Lot: lot SDFC- exp. 5/31/2024 lot TFBW- exp. 5/31/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviation: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
EPI Health, LLC
Distributor
US Nationwide
Lot
lot SDFC- exp. 5/31/2024 lot TFBW- exp. 5/31/2025
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Cloderm (clocortolone pivalate) Cream, 0.1%, Rx Only, For Topical Use Only, Net Wt 45g, Manufactured for: EPI Health, LLC, Charleston, SC 29403, NDC 71403-804-90 recalled?

Yes. FDA published recall D-0473-2024 on May 1, 2024. Reported hazard: CGMP Deviation: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.

What should I do if I have this product?

Voluntary: Firm initiated · Letter